Epizyme Inc
F:EPE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Epizyme Inc
F:EPE
|
US |
|
Aviva PLC
F:GU80
|
UK |
|
Pharnext SCA
OTC:PNEXF
|
FR |
|
U
|
UniCredit SpA
OTC:UNCFF
|
IT |
|
S
|
Salesforce Inc
XBER:FOO
|
US |
|
Zillow Group Inc
NASDAQ:ZG
|
US |
|
L
|
Las Vegas Sands Corp
BMV:LVS
|
US |
|
V
|
Volkswagen AG
WSE:VOW
|
DE |
|
Nextera Energy Inc
NYSE:NEE
|
US |
|
Fast Retailing Co Ltd
TSE:9983
|
JP |
|
People.cn Co Ltd
SSE:603000
|
CN |
|
F
|
Federal Home Loan Mortgage Corp
OTC:FMCC
|
US |
|
K
|
Krones AG
F:KRN
|
DE |
Bankruptcy Probability
Epizyme Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Epizyme Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
10.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
|
2.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
FibroGen Inc
NASDAQ:FGEN
|
32.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
364.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
178B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
165.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
107.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
74.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Epizyme Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Epizyme Inc has total debt of 232.9m USD. This includes both short-term (0 USD) and long-term (232.9m USD) debt.
You can find a full breakdown on its Balance Sheet.
